In 5/80 (6.3%) of the EM patients, the WES analysis allowed for the identification of different novel, predicted, and highly impacting missense variants within the LAMA5 gene; all these selected variants belong to domains of the encoded protein predicted as intolerant to missense variation. The gene discussed is LAMA5; the disease is erythema multiforme.